The DOI matches its Crossref record; 214 of the 214 references it cites were found in a registry or an index.
First-line drugs for hypertension
Open accessAbstract
BACKGROUND: This is the first update of a review published in 2009. Sustained moderate to severe elevations in resting blood pressure leads to a critically important clinical question: What class of drug to use first-line? This review attempted to answer that question. OBJECTIVES: To quantify the mortality and morbidity effects from different first-line antihypertensive drug classes: thiazides (low-dose and high-dose), beta-blockers, calcium channel blockers, ACE inhibitors, angiotensin II receptor blockers (ARB), and alpha-blockers, compared to placebo or no treatment.Secondary objectives: when different antihypertensive drug classes are used as the first-line drug, to quantify the blood pressure lowering effect and the rate of withdrawal due to adverse drug effects, compared to placebo or no treatment. SEARCH METHODS: The Cochrane Hypertension Information Specialist searched the following databases for randomized controlled trials up to November 2017: the Cochrane Hypertension Specialised Register, the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE (from 1946), Embase (from 1974), the World Health Organization International Clinical Trials Registry Platform, and ClinicalTrials.gov. We contacted authors of relevant papers regarding further published and unpublished work. SELECTION CRITERIA: Randomized trials (RCT) of at least one year duration, comparing one of six major drug classes with a placebo or no treatment, in adult patients with blood pressure over 140/90 mmHg at baseline. The majority (over 70%) of the patients in the treatment group were taking the drug class of interest after one year. We included trials with both hypertensive and normotensive patients in this review if the majority (over 70%) of patients had elevated blood pressure, or the trial separately reported outcome data on patients with elevated blood pressure. DATA COLLECTION AND ANALYSIS: The outcomes assessed were mortality, stroke, coronary heart disease (CHD), total cardiovascular events (CVS), decrease in systolic and diastolic blood pressure, and withdrawals due to adverse drug effects. We used a fixed-effect model to to combine dichotomous outcomes across trials and calculate risk ratio (RR) with 95% confidence interval (CI). We presented blood pressure data as mean difference (MD) with 99% CI. MAIN RESULTS: The 2017 updated search failed to identify any new trials. The original review identified 24 trials with 28 active treatment arms, including 58,040 patients. We found no RCTs for ARBs or alpha-blockers. These results are mostly applicable to adult patients with moderate to severe primary hypertension. The mean age of participants was 56 years, and mean duration of follow-up was three to five years.High-quality evidence showed that first-line low-dose thiazides reduced mortality (11.0% with control versus 9.8% with treatment; RR 0.89, 95% CI 0.82 to 0.97); total CVS (12.9% with control versus 9.0% with treatment; RR 0.70, 95% CI 0.64 to 0.76), stroke (6.2% with control versus 4.2% with treatment; RR 0.68, 95% CI 0.60 to 0.77), and coronary heart disease (3.9% with control versus 2.8% with treatment; RR 0.72, 95% CI 0.61 to 0.84).Low- to moderate-quality evidence showed that first-line high-dose thiazides reduced stroke (1.9% with control versus 0.9% with treatment; RR 0.47, 95% CI 0.37 to 0.61) and total CVS (5.1% with control versus 3.7% with treatment; RR 0.72, 95% CI 0.63 to 0.82), but did not reduce mortality (3.1% with control versus 2.8% with treatment; RR 0.90, 95% CI 0.76 to 1.05), or coronary heart disease (2.7% with control versus 2.7% with treatment; RR 1.01, 95% CI 0.85 to 1.20).Low- to moderate-quality evidence showed that first-line beta-blockers did not reduce mortality (6.2% with control versus 6.0% with treatment; RR 0.96, 95% CI 0.86 to 1.07) or coronary heart disease (4.4% with control versus 3.9% with treatment; RR 0.90, 95% CI 0.78 to 1.03), but reduced stroke (3.4% with control versus 2.8% with treatment; RR 0.83, 95% CI 0.72 to 0.97) and total CVS (7.6% with control versus 6.8% with treatment; RR 0.89, 95% CI 0.81 to 0.98).Low- to moderate-quality evidence showed that first-line ACE inhibitors reduced mortality (13.6% with control versus 11.3% with treatment; RR 0.83, 95% CI 0.72 to 0.95), stroke (6.0% with control versus 3.9% with treatment; RR 0.65, 95% CI 0.52 to 0.82), coronary heart disease (13.5% with control versus 11.0% with treatment; RR 0.81, 95% CI 0.70 to 0.94), and total CVS (20.1% with control versus 15.3% with treatment; RR 0.76, 95% CI 0.67 to 0.85).Low-quality evidence showed that first-line calcium channel blockers reduced stroke (3.4% with control versus 1.9% with treatment; RR 0.58, 95% CI 0.41 to 0.84) and total CVS (8.0% with control versus 5.7% with treatment; RR 0.71, 95% CI 0.57 to 0.87), but not coronary heart disease (3.1% with control versus 2.4% with treatment; RR 0.77, 95% CI 0.55 to 1.09), or mortality (6.0% with control versus 5.1% with treatment; RR 0
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ahmed, A., Jorna, T., & Bhandari, S. (2016) · Nephron · doi:10.1159/000447068 · Cited by 11,717
(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420301 · Cited by 8,663
Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493
Stearne, M. R., Palmer, S. L., Hammersley, M. S., Franklin, S. L., Spivey, R. S., Lévy, J., Tidy, C. R., Bell, N. J., Steemson, J., Barrow, B. A., et al. (1998) · UCL Discovery (University College London) · Cited by 6,094
Lewis, E. J., Hunsicker, L. G., Clarke, W. R., Berl, T., Pohl, M. A., Lewis, J. B., Ritz, E., Atkins, R. C., Rohde, R., & Raz, I. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011303 · Cited by 5,987
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy
Lewis, E. J., Hunsicker, L. G., Bain, R. P., & Rohde, R. D. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311113292004 · Cited by 5,394
Blood pressure, stroke, and coronary heart disease
Collins, R., Peto, R., MacMahon, S., Godwin, J., Qizilbash, N., Collins, R., MacMahon, S., Hebert, P., Eberlein, K. A., Taylor, J. O., et al. (1990) · The Lancet · doi:10.1016/0140-6736(90)90944-z · Cited by 4,491
Treatment of hypertension in patients 80 years of age or older
Beckett, N. S., Peters, R., Fletcher, A. E., Staessen, J. A., Liu, L., Dumitrascu, D., Stoyanovsky, V., Antikainen, R. L., Nikitin, Y., Anderson, C., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801369 · Cited by 3,092
Staessen, J. A., Fagard, R., Thijs, L., Celis, H., Arabidze, G. G., Birkenhäger, W. H., Bulpitt, C. J., de Leeuw, P. W., Dollery, C. T., Fletcher, A. E., et al. (1997) · The Lancet · doi:10.1016/s0140-6736(97)05381-6 · Cited by 2,989
The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes
Parving, H.-H., Lehnert, H., Bröchner-Mortensen, J., Gomis, R., Andersen, S., & Arner, P. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011489 · Cited by 2,873
Law, M. R., Morris, J. K., & Wald, N. J. (2009) · BMJ · doi:10.1136/bmj.b1665 · Cited by 2,775
[Effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes].
Parving, H., Lehnert, H., Brøchner‐Mortensen, J., Gomis, R., Andersen, S., & Arner, P. (2001) · PubMed · Cited by 2,535
Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)
Dahlöf, B., Hansson, L., Lindholm, L. H., Scherstén, B., Ekbom, T., & Wester, P.-O. (1991) · The Lancet · doi:10.1016/0140-6736(91)92589-t · Cited by 1,881
The J-Curve Phenomenon in Hypertension
Kang, Y.-Y., & Wang, J.-G. (2016) · Pulse · doi:10.1159/000446922 · Cited by 1,530
Kinaan, M., Ding, H., & Triggle, C. R. (2015) · Medical Principles and Practice · doi:10.1159/000381643 · Cited by 1,515
The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group (2000) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.283.15.1967 · Cited by 1,499
AMERY, A. (1985) · The Lancet · doi:10.1016/s0140-6736(85)91783-0 · Cited by 1,476
Lithell, H., Hansson, L., Skoog, I., Elmfeldt, D., Hofman, A., Olofsson, B., Trenkwalder, P., & Zanchetti, A. (2003) · Journal of Hypertension · doi:10.1097/00004872-200305000-00011 · Cited by 1,409
Stearne, M. R., Palmer, S. L., Hammersley, M. S., Franklin, S. L., Spivey, R. S., Lévy, J., Tidy, C. R., Bell, N. J., Steemson, J., Barrow, B. A., et al. (1998) · UCL Discovery (University College London) · Cited by 1,406
Medical Research Council trial of treatment of hypertension in older adults: principal results.
Peart, S., Brennan, P. J., Broughton, P., Dollery, C. T., Hudson, M. F., Lever, A. F., Meade, T. W., Rose, G., & Pocock, S. (1992) · Cited by 1,360
(1967) · JAMA · doi:10.1001/jama.202.11.1028 · Cited by 1,298
Brown, M. J., Palmer, C. R., Castaigne, A., de Leeuw, P. W., Mancia, G., Rosenthal, T., & Ruilope, L. M. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02527-7 · Cited by 1,209
Materson, B. J., Reda, D. J., Cushman, W. C., Massie, B. M., Freis, E. D., Kochar, M. S., Hamburger, R. J., Fye, C., Lakshman, R., Gottdiener, J., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199304013281303 · Cited by 1,199
Angiotensin-converting-enzyme inhibition in stable coronary artery disease
(2004) · New England Journal of Medicine · doi:10.1056/nejmoa042739 · Cited by 1,123
Psaty, B. M., Lumley, T., Furberg, C. D., Schellenbaum, G., Pahor, M., Alderman, M. H., & Weiss, N. S. (2003) · JAMA · doi:10.1001/jama.289.19.2534 · Cited by 1,088
Preventing Microalbuminuria in Type 2 Diabetes
Ruggenenti, P., Fassi, A., Ilieva, A. P., Bruno, S., Iliev, I. P., Brusegan, V., Rubis, N., Gherardi, G., Arnoldi, F., Ganeva, M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa042167 · Cited by 1,020
Neaton, J. D. (1993) · JAMA · doi:10.1001/jama.270.6.713 · Cited by 946
Curb, J. D. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540230036032 · Cited by 930
Hansson, L., Hedner, T., Lund-Johansen, P., Kjeldsen, S. E., Lindholm, L. H., Syvertsen, J. O., Lanke, J., de Faire, U., Dahlöf, B., & Karlberg, B. E. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02526-5 · Cited by 905
Psaty, B. M. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540330061036 · Cited by 875
Solomon, S. (1969) · The Lancet · doi:10.1016/s0140-6736(69)92136-9 · Cited by 844
Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes
Haller, H., Ito, S., Izzo, J. L., Januszewicz, A., Katayama, S., Menne, J., Mimran, A., Rabelink, T. J., Ritz, E., Ruilope, L. M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1007994 · Cited by 792
Telmisartan to Prevent Recurrent Stroke and Cardiovascular Events
Yusuf, S., Diener, H.-C., Sacco, R. L., Cotton, D., Ôunpuu, S., Lawton, W. A., Palesch, Y., Martin, R. H., Albers, G. W., Bath, P., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0804593 · Cited by 785
Peters, R., Beckett, N., Forette, F., Tuomilehto, J., Clarke, R., Ritchie, C., Waldman, A., Walton, I., Poulter, R., Ma, S., et al. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70143-1 · Cited by 770
Effect of ramipril on the incidence of diabetes
(2006) · New England Journal of Medicine · doi:10.1056/nejmoa065061 · Cited by 737
Randomised trial of treatment of hypertension in elderly patients in primary care.
Coope, J., & Warrender, T. S. (1986) · BMJ · doi:10.1136/bmj.293.6555.1145 · Cited by 725
Effect of valsartan on the incidence of diabetes and cardiovascular events
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001121 · Cited by 660
Letter: Immunotherapy for colorectal cancer.
Hsu, L. Y., David, K., Serotkin, A. V., Godmilov, L., & Hirschhorn, K. (1976) · PubMed · Cited by 652
Treatment of mild hypertension: A five year controlled drug trial
Helgeland, A. (1980) · The American Journal of Medicine · doi:10.1016/0002-9343(80)90438-6 · Cited by 638
Antihypertensive drugs in very old people: a subgroup meta-analysis of randomised controlled trials
Gueyffier, F., Bulpitt, C., Boissel, J.-P., Schron, E., Ekbom, T., Fagard, R., Casiglia, E., Kerlikowske, K., & Coope, J. (1999) · The Lancet · doi:10.1016/s0140-6736(98)08127-6 · Cited by 632
Neoptolemos, J., Kemppainen, E., Mayer, J., Fitzpatrick, J., Raraty, M., Slavin, J., Beger, H.-G., Hietaranta, A., & Puolakkainen, P. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02327-8 · Cited by 623
Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease
Lonn, E. M., Bosch, J., López-Jaramillo, P., Zhu, J., Liu, L., Pais, P., Diaz, R., Xavier, D., Sliwa, K., Dans, A., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1600175 · Cited by 618
Davis, B. (1996) · American Journal of Hypertension · doi:10.1016/0895-7061(96)00037-4 · Cited by 595
(1970) · JAMA · doi:10.1001/jama.213.7.1143 · Cited by 554
Greenburg, G. A. (1981) · PubMed · Cited by 545
UK prospective diabetes study (UKPDS): VIII. Study design, progress and performance
UK Prospective Diabetes Study Group (1991) · Diabetologia · doi:10.1007/bf00400195 · Cited by 543
The Australian therapeutic trial in mild hypertension.
Abernethy, J. D. (1984) · Hypertension · doi:10.1161/01.hyp.6.5.774 · Cited by 516
Kostis, J. B. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03550030052033 · Cited by 494
Beta-blockers for hypertension
Wiysonge, C. S., Bradley, H. A., Volmink, J., Mayosi, B. M., & Opie, L. H. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002003.pub5 · Cited by 474
Post-stroke antihypertensive treatment study. A preliminary result.
Pats, & Collaborating (1995) · Chinese Medical Journal · Cited by 467
Beta-Blockers Versus Diuretics in Hypertensive Men: Main Results from the HAPPHY Trial
Wilhelmsen, L., Berglund, G., Elmfeldt, D., Fitzsimons, T., Holzgreve, H., Hosie, J., H??rnkvist, P.-E., Pennert, K., Tuomilehto, J., & Wedel, H. (1987) · Journal of Hypertension · doi:10.1097/00004872-198710000-00009 · Cited by 463
Shanghai trial of nifedipine in the elderly
Gong, L., Zhang, W., Zhu, Y., Zhu, J., kong, D., Pag??, V., Ghadirian, P., LeLorier, J., & Hamet, P. (1996) · Journal of Hypertension · doi:10.1097/00004872-199610000-00013 · Cited by 412
Wikstrand, J. (1988) · JAMA · doi:10.1001/jama.259.13.1976 · Cited by 408
Berl, T., Hunsicker, L. G., Lewis, J. B., Pfeffer, M. A., Porush, J. G., Rouleau, J.-L., Drury, P. L., Esmatjes, E., Hricik, D., Parikh, C. R., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-7-200304010-00010 · Cited by 402
Thomopoulos, C., Parati, G., & Zanchetti, A. (2014) · Journal of Hypertension · doi:10.1097/hjh.0000000000000378 · Cited by 388
The Australian Therapeutic Trial in Mild Hypertension
Doyle, A. E. (1987) · Nephron · doi:10.1159/000184567 · Cited by 385
Treatment of mild hypertension: results of a ten-year intervention trial.
Wm, S. (1977) · Circulation Research · Cited by 350
Hypertension Detection and Follow-up Program Cooperative Group* (1982) · New England Journal of Medicine · doi:10.1056/nejm198210143071603 · Cited by 338
Change in Depression as a Precursor of Cardiovascular Events
Wassertheil-Smoller, S. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.1996.00440050111012 · Cited by 319
Franse, L. V., Pahor, M., Bari, M. D., Shorr, R. I., Wan, J. Y., Somes, G. W., & Applegate, W. B. (2000) · Journal of Hypertension · doi:10.1097/00004872-200018080-00021 · Cited by 307
Borhani, N. O. (1996) · JAMA · doi:10.1001/jama.1996.03540100029024 · Cited by 302
Results of the pilot study for the Hypertension in the Very Elderly Trial
Bulpitt, C. J., Beckett, N. S., Cooke, J., Dumitrascu, D. L., Gil-Extremera, B., Nachev, C., Nunes, M., Peters, R., Staessen, J. A., & Thijs, L. (2003) · Journal of Hypertension · doi:10.1097/00004872-200312000-00030 · Cited by 296
Marre, M., Lievre, M., Chatellier, G., Mann, J. F. E., Passa, P., & Ménard, J. (2004) · BMJ · doi:10.1136/bmj.37970.629537.0d · Cited by 296
Savage, P. J. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.7.741 · Cited by 292
Teo, K. K., Burton, J. R., Buller, C. E., Plante, S., Catellier, D., Tymchak, W., Dzavik, V., Taylor, D., Yokoyama, S., & Montague, T. J. (2000) · Circulation · doi:10.1161/01.cir.102.15.1748 · Cited by 275
60才以上の患者における年齢,性,血圧,及び心血管疾患既往症に関する抗高血圧剤治療の効果
Amery, A., Birkenhaeger, W., Brixko, R., Bulpitt, C. J., Clement, D., Deruyttere, M., SCHAEPDRYVER, A. D., Dollery, C., & Fagard, R. H. (1986) · The Lancet · Cited by 263
Effects of Blood Pressure Reduction in Mild Hypertension: A Systematic Review and Meta-analysis
Sundström, J., Arima, H., Jackson, R., Turnbull, F., Rahimi, K., Chalmers, J., Woodward, M., Neal, B., & on behalf of the Blood Pressure Lowering Treatment Trialists' Collaboration* (2015) · Annals of Internal Medicine · doi:10.7326/m14-0773 · Cited by 262
HYPOTENSIVE THERAPY IN STROKE SURVIVORS
Carter, A. B. (1970) · The Lancet · doi:10.1016/s0140-6736(70)91577-1 · Cited by 259
Hou, F. F., Xie, D., Zhang, X., Chen, P. Y., Zhang, W. R., Liang, M., Guo, Z. J., & Jiang, J. P. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006121372 · Cited by 251
Irbesartan in Patients with Atrial Fibrillation
(2011) · New England Journal of Medicine · doi:10.1056/nejmoa1008816 · Cited by 249
Mechanisms for blood pressure lowering and metabolic effects of thiazide and thiazide-like diuretics
Duarte, J. D., & Cooper-DeHoff, R. M. (2010) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.10.27 · Cited by 237
Beta-blockers for hypertension
Wiysonge, C. S., Bradley, H., Mayosi, B. M., Maroney, R. T., Mbewu, A. D., Opie, L. H., & Volmink, J. A. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002003.pub2 · Cited by 237
for the ORIENT study investigators, Imai, E., Chan, J. C. N., Ito, S., Yamasaki, T., Kobayashi, F., Haneda, M., & Makino, H. (2011) · Diabetologia · doi:10.1007/s00125-011-2325-z · Cited by 236
Drug Treatment of Hypertension in the Elderly: A Meta-Analysis
Insua, J. T., Sacks, H. S., Lau, T.-S., Lau, J., Reitman, D., Pagano, D., & Chalmers, T. C. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-5-199409010-00008 · Cited by 236
Alterations in canine myocardial excitability during ischemia.
Elharrar, V, Foster, P. R., Jirak, T. L., Gaum, W. E., & Zipes, D. P. (1977) · Circulation Research · doi:10.1161/01.res.40.1.98 · Cited by 235
MacMahon, S., Sharpe, N., Gamble, G., Clague, A., Ni Mhurchu, C., Clark, T., Hart, H., Scott, J., & White, H. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00736-1 · Cited by 235
Pitt, B., O’Neill, B., Feldman, R., Ferrari, R., Schwartz, L., Mudra, H., Bass, T., Pepine, C., Texter, M., Haber, H., et al. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01461-8 · Cited by 231
Staessen, J., Bulpitt, C., Clement, D., De Leeuw, P., Fagard, R., Fletcher, A., Forette, F., Leonetti, G., Nissinen, A., & O'Malley, K. (1989) · BMJ · doi:10.1136/bmj.298.6687.1552 · Cited by 228
Hypertension in the elderly. Implications and generalizability of randomized trials
Mulrow, C. D. (1994) · JAMA · doi:10.1001/jama.272.24.1932 · Cited by 225
Pharmacotherapy for hypertension in the elderly
Musini, V. M., Tejani, A. M., Bassett, K., & Wright, J. M. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000028.pub2 · Cited by 218
Self-citationThe Australian therapeutic trial in mild hypertension. Report by the Management Committee.
(1980) · PubMed · Cited by 215
Amery, A., Birkenhäger, W. H., Brixko, P., Bulpitt, C. J., Clément, D., de Leeuw, P. W., Jf, D. P., Deruyttere, M., SCHAEPDRYVER, A. D., & Dollery, C. T. (1986) · PubMed · Cited by 210
Department of veterans affairs single-drug therapy of hypertension studyRevised figures and new data
MATERSON, B., REDA, D., & CUSHMAN, W. (1995) · American Journal of Hypertension · doi:10.1016/0895-7061(94)00196-i · Cited by 205
A meta-analysis of outcome trials in elderly hypertensives
Thijs, L., Fagard, R., Lijnen, P., Staessen, J., Van Hoof, R., & Amery, A. (1992) · Journal of Hypertension · doi:10.1097/00004872-199210000-00001 · Cited by 204
Strandberg, T. E., Salomaa, V. V., Naukkarinen, V. A., Vanhanen, H. T., Sarna, S. J., & Miettinen, T. A. (1991) · JAMA · doi:10.1001/jama.1991.03470090059032 · Cited by 202
Systolic Hypertension in the Elderly Program (SHEP): Antihypertensive efficacy of chlorthalidone
Hulley, S. B., Furberg, C. D., Gurland, B., McDonald, R., Perry, H. M., Schnaper, H. W., Schoenberger, J. A., Smith, W. M., & Vogt, T. M. (1985) · The American Journal of Cardiology · doi:10.1016/0002-9149(85)90404-7 · Cited by 197
Pharmacotherapy for mild hypertension
Diao, D., Wright, J. M., Cundiff, D. K., & Gueyffier, F. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006742.pub2 · Cited by 194
Self-citationUK Prospective Diabetes Study (UKPDS). VIII. Study design, progress and performance.
(1991) · PubMed · Cited by 191
Mac Mahon, S., & Rodgers, A. (1993) · Clinical and Experimental Hypertension · doi:10.3109/10641969309037085 · Cited by 184
Randomized Controlled Trials of Blood Pressure Lowering in Hypertension: A Critical Reappraisal
Zanchetti, A., Thomopoulos, C., & Parati, G. (2015) · Circulation Research · doi:10.1161/circresaha.116.303641 · Cited by 183
Mortality over Four Years in SHEP Participants with a Low Ankle‐Arm Index
Newman, A. B., Tyrrell, K. S., & Kuller, L. H. (1997) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1997.tb03198.x · Cited by 182
Strandberg, T. E., Salomaa, V. V., Naukkarinen, V., Vanhanen, H. T., Sarna, S. J., & Miettinen, T. A. (1991) · PubMed · Cited by 179
Post-stroke antihypertensive treatment study. A preliminary result.
(1995) · PubMed · Cited by 170
Applegate, W. B., Davis, B. R., Black, H. R., Smith, W. M., Miller, S. T., & Burlando, A. J. (1991) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1991.tb02869.x · Cited by 168
Philipp, T., Anlauf, M., Distler, A., Holzgreve, H., Michaelis, J., & Wellek, S. (1997) · BMJ · doi:10.1136/bmj.315.7101.154 · Cited by 168
Wright, J. M., Lee, C., & Chambers, G. K. (1999) · Europe PMC (PubMed Central) · Cited by 167
Self-citationBERGLUND, G. (1981) · The Lancet · doi:10.1016/s0140-6736(81)92624-6 · Cited by 166
Mindlen, F., Nordaby, R. A., Ruiz, M. I. S., Nava-Zavala, A. H., Guzmán, L., Martínez, F., Díaz, R., Mackey, C., Marino, M., Romero, G. S., et al. (1996) · PubMed · Cited by 160
Rouleau, J. L., Warnica, W. J., Baillot, R., Block, P. J., Chocron, S., Johnstone, D., Myers, M. G., Calciu, C.-D., Dalle-Ave, S., Martineau, P., et al. (2008) · Circulation · doi:10.1161/circulationaha.106.685073 · Cited by 158
Report by the Management Committee (1981) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1981.tb101027.x · Cited by 158
Effects of treatment in hypertension results of a controlled study
Wolff, F. W., & Lindeman, R. D. (1966) · Journal of Chronic Diseases · doi:10.1016/0021-9681(66)90128-7 · Cited by 151
Clinical results of the Verapamil in Hypertension and Atherosclerosis Study
Rosei, E. A., Palù, C. D., Leonetti, G., Magnani, B., Pessina, A. C., & Zanchetti, A. (1997) · Journal of Hypertension · doi:10.1097/00004872-199715110-00019 · Cited by 150
Serum Lipids and Incidence of Coronary Heart Disease
Frost, P. H., Davis, B. R., Burlando, A. J., Curb, J. D., Guthrie, G. P., Isaacsohn, J. L., Wassertheil-Smoller, S. W., Wilson, A. C., & Stamler, J. (1996) · Circulation · doi:10.1161/01.cir.94.10.2381 · Cited by 147
Relation of Low Body Mass to Death and Stroke in the Systolic Hypertension in the Elderly Program
Wassertheil-Smoller, S. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.4.494 · Cited by 144
Atenolol in Secondary Prevention after Stroke
Eriksson, S., Olofsson, B., & Wester, P. (1995) · Cerebrovascular Diseases · doi:10.1159/000107813 · Cited by 142
Schmieder, R. E., Philipp, T., Guerediaga, J., Gorostidi, M., Smith, B. A., Weissbach, N., Maboudian, M., Botha, J., & van Ingen, H. (2009) · Circulation · doi:10.1161/circulationaha.107.750745 · Cited by 141
Metoprolol versus thiazide diuretics in hypertension. Morbidity results from the MAPHY Study.
Wikstrand, J., Warnold, I., Tuomilehto, J., Olsson, G., Barber, H. J., Eliasson, K., Elmfeldt, D., Jastrup, B., KARATZAS, N. B., & Leer, J. (1991) · Hypertension · doi:10.1161/01.hyp.17.4.579 · Cited by 136
Staessen, J. A., Fagard, R., Thijs, L., Celis, H., Birkenhäger, W. H., Bulpitt, C., de Leeuw, P. W., FLETCHER, A. E., Babarskienė, M., Forette, F., et al. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.15.1681 · Cited by 135
Lifestyle Intervention: Results of the Treatment of Mild Hypertension Study (TOMHS)
Elmer, P. J., Grimm, R. A., Laing, B., Grandits, G. A., Svendsen, K. H., VanHeel, N., Betz, E., Raines, J., Link, M., Stamler, J., et al. (1995) · Preventive Medicine · doi:10.1006/pmed.1995.1062 · Cited by 132
Morbidity and mortality in the Systolic Hypertension in the Elderly Program (SHEP) pilot study.
Perry, H. M., Smith, W. M., McDonald, R. H., Black, D. M., Cutler, J. A., Furberg, C. D., Greenlick, M. R., Kuller, L. H., Schnaper, H. W., & Schoenberger, J. A. (1989) · Stroke · doi:10.1161/01.str.20.1.4 · Cited by 129
Amery, A., Birkenhäger, W. H., Bulpitt, C., Clément, D., de Leeuw, P. W., Dollery, C. T., Fagard, R. H., Fletcher, A., Forette, F., Leonetti, G., et al. (1991) · Aging Clinical and Experimental Research · doi:10.1007/bf03324024 · Cited by 124
(1988) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(88)90024-8 · Cited by 115
Pharmacotherapy for hypertension in the elderly
Mulrow, C. D., Lau, J., Cornell, J., & Brand, M. (1998) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000028 · Cited by 112
Gueyffier, F., Froment, A., & Gouton, M. (1996) · PubMed · Cited by 111
Helgeland, A., Hjermann, I., Holme, I., & Leren, P. (1978) · The American Journal of Medicine · doi:10.1016/0002-9343(78)90177-8 · Cited by 109
SCREENING FOR BREAST CANCER: THE ROLE OF MAMMOGRAPHY
Christie, D. G. S. (1977) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1977.tb114570.x · Cited by 106
Hood, S. J., Taylor, K., Ashby, M. J., & Mj, B. (2007) · Circulation · doi:10.1161/circulationaha.107.690396 · Cited by 105
Recruitment of elderly volunteers for a multicenter clinical trial: The SHEP pilot study
VOGT, T. M., Ireland, C. C., Black, D. M., Camel, G. H., & Hughes, G. H. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90028-0 · Cited by 101
Thomopoulos, C., Parati, G., & Zanchetti, A. (2016) · Journal of Hypertension · doi:10.1097/hjh.0000000000000848 · Cited by 100
Calcium channel blockers versus other classes of drugs for hypertension
Chen, N., Zhou, M., Yang, M., Guo, J., Zhu, C., Yang, J., Wang, Y., Yang, X., & He, L. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003654.pub4 · Cited by 99
Dahlöf, B., Hansson, L., Lindholm, L. H., Scherstén, B., Wester, P. O., Ekbom, T., Hedner, T., & Fairé, U. D. (1993) · Blood Pressure · doi:10.3109/08037059309077541 · Cited by 96
EVALUATION OF DRUG TREATMENT IN MILD HYPERTENSION: VA‐NHLBI FEASIBILITY TRIAL*
Neurath, H. M., Goldman, A. I., Lavin, M. A., Schnaper, H. W., Fitz, A. E., Frohlich, E. D., Steele, B. W., & Richman, H. G. (1978) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1978.tb25604.x · Cited by 91
Blood pressure reduction in elderly: a randomised controlled trial of methyldopa.
Sprackling, M., Mitchell, J. R. A., Short, A. H., & Watt, G. C. M. (1981) · BMJ · doi:10.1136/bmj.283.6300.1151 · Cited by 90
Treatment of Hypertension in Patients 80 Years of Age or Older
Elliott, W. J. (2009) · Yearbook of Cardiology · doi:10.1016/s0145-4145(08)79311-0 · Cited by 89
Prospective study on the treatment of mild hypertension in the aged.
Kuramoto, K., Matsushita, S., Kuwajima, I., & Murakami, M. (1981) · Japanese Heart Journal · doi:10.1536/ihj.22.75 · Cited by 88
FAILURE OF THERAPY TO IMPROVE PROGNOSIS IN ELDERLY MALES WITH HYPERTENSION
Morgan, T. O., Adams, W. R., Hodgson, M., & Gibberd, R. W. (1980) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1980.tb131808.x · Cited by 88
Compliance to Treatment for Hypertension in Elderly Patients: The Shep Pilot Study
Black, D. M., Brand, R., Greenlick, M. R., Hughes, G., & Smith, J. J. B. (1987) · Journal of Gerontology · doi:10.1093/geronj/42.5.552 · Cited by 87
Casiglia, E., Spolaore, P., Mazza, A., Ginocchio, G., COLANGELI, G., Onesto, C., Menza, G. D., Pegoraro, L., & Ambrosio, G. B. (1994) · Japanese Heart Journal · doi:10.1536/ihj.35.589 · Cited by 86
How do thiazide and thiazide-like diuretics lower blood pressure?
Hughes, A. D. (2004) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.3317/jraas.2004.034 · Cited by 85
Systolic Hypertension in the Elderly Program (SHEP): The First Three Months
Hulley, S. B., Feigal, D. W., Ireland, C., Kuller, L. H., & Smith, W. M. (1986) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1986.tb05476.x · Cited by 84
Pool, J. L., Glazer, R. D., Weinberger, M. H., Alvarado, R., Huang, J., & Graff, A. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.01.007 · Cited by 83
Pharmacotherapy for hypertension in adults aged 18 to 59 years
Musini, V. M., Gueyffier, F., Puil, L. J., Salzwedel, D. M., & Wright, J. M. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008276.pub2 · Cited by 80
Self-citationBearden, D. M., Allman, R. M., McDonald, R., Miller, S., Presse, S., & Petrovitch, H. (1994) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1994.tb06979.x · Cited by 79
Risks and benefits in the trial of the European Working Party on High Blood Pressure in the Elderly
FLETCHER, A. E., Amery, A. A., Birkenhäger, W. H., Bulpitt, C. J., Clement, D. L., de Leeuw, P. W., Deruyttere, M., Schaepdryver, A. D., Dollery, C. T., Fagard, R., et al. (1991) · Journal of Hypertension · doi:10.1097/00004872-199103000-00005 · Cited by 75
Berglund, G. L., ANDERSSON, O., & Widgren, B. R. (1986) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1986.tb02790.x · Cited by 74
The Hypertension in the Very Elderly Trial (HYVET)
Bulpitt, C. J., FLETCHER, A. E., Amery, A. K. P. C., Coope, J., Evans, J. G., Lightowlers, S., O'MALLEY, K., Palmer, A., Potter, J. F., Sever, P., et al. (1994) · Drugs & Aging · doi:10.2165/00002512-199405030-00003 · Cited by 74
Xue, H., Lu, Z., Tang, W. L., Pang, L. W., Wang, G. M., Wong, G. W., & Wright, J. M. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008170.pub2 · Cited by 71
Self-citationHiltunen, T. P., Suonsyrjä, T., Hannila‐Handelberg, T., Paavonen, K., Miettinen, H. E., Strandberg, T. E., Tikkanen, I. T., Tilvis, R. S., Pentikäinen, P. J., & Virolainen, J. (2007) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2006.09.006 · Cited by 70
Puttnam, R., Davis, B. R., Pressel, S., Whelton, P. K., Cushman, W. C., Louis, G. T., Margolis, K. L., Oparil, S., Williams, J. S., Ghosh, A., et al. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.6821 · Cited by 70
Australian Therapeutic Trial in Mild Hypertension
Reader, R. (1984) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1984.tb132588.x · Cited by 67
Matsuoka, H. (1995) · Hypertension Research · doi:10.1291/hypres.18.235 · Cited by 67
British Medical Journal Publishing Group (1986) · BMJ · doi:10.1136/bmj.293.6553.988 · Cited by 67
Zhu, Z., Zhu, S., Liu, D., Cao, T., Wang, L., & Tepel, M. (2004) · Hypertension · doi:10.1161/01.hyp.0000152701.97426.5f · Cited by 62
Helgeland, A., Leren, P., FOSS, O. P., Hjermann, I., Holme, I., & Lund‐Larsen, P. G. (1984) · The American Journal of Medicine · doi:10.1016/0002-9343(84)90990-2 · Cited by 61
Kondo, J., Sone, T., Tsuboi, H., Mukawa, H., Morishima, I., Uesugi, M., Kono, T., Kosaka, T., Yoshida, T., Numaguchi, Y., et al. (2003) · American Heart Journal · doi:10.1016/s0002-8703(03)00443-5 · Cited by 59
Leren, P., & Helgeland, A. (1986) · Drugs · doi:10.2165/00003495-198600311-00008 · Cited by 58
Treatment of mild hypertension. Preliminary results of a two-year feasibility trial.
Perry, H. M. (1977) · PubMed · Cited by 56
(2000) · doi:10.1007/978-1-4615-6767-7 · Cited by 54
Control of Moderately Raised Blood Pressure: REPORT OF A CO-OPERATIVE RANDOMIZED TRIAL
(1973) · BMJ · doi:10.1136/bmj.3.5877.434 · Cited by 52
de Leeuw, P. W. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90436-2 · Cited by 51
Coronary heart disease and treatment of hypertension some Oslo study data
Leren, P., & Helgeland, A. (1986) · The American Journal of Medicine · doi:10.1016/0002-9343(86)90153-1 · Cited by 51
Fletcher, A. E. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90435-z · Cited by 49
Dens, J., Desmet, W. J., Coussement, P., Scheerder, I. K. D., Kostopoulos, K., Kerdsinchai, P., Supanantaroek, C., & Piessens, J. (2003) · Heart · doi:10.1136/heart.89.8.887 · Cited by 47
Hansson, L., & Zanchetti, A. (1995) · Blood Pressure · doi:10.3109/08037059509077613 · Cited by 45
Systolic Hypertension in the Elderly Program (SHEP). Part 1: Rationale and design.
Borhani, N. O., Applegate, W. B., Cutler, J. A., Davis, B. R., Furberg, C. D., Lakatos, E., Page, L. B., Perry, H. M., Smith, W. M., & Probstfield, J. L. (1991) · Hypertension · doi:10.1161/01.hyp.17.3_suppl.ii2 · Cited by 45
The Oslo study: CHD risk factors, socioeconomic influences, and intervention
Leren, P., Helgeland, A., Hjermann, I., & Holme, I. (1983) · American Heart Journal · doi:10.1016/0002-8703(83)90175-8 · Cited by 45
Tuomilehto, J. O. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90434-y · Cited by 42
Beckett, N., Connor, M., Sadler, J., Fletcher, A., Bulpitt, C., & on behalf of the HYVET investigators (1999) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1000901 · Cited by 41
Jusufovic, M., Sandset, E. C., Bath, P. M., Karlson, B. W., & Berge, E. (2014) · International Journal of Stroke · doi:10.1111/ijs.12418 · Cited by 40
Wh, B., Staessen, J. A., Gąsowski, J., & de Leeuw, P. W. (2000) · PubMed · Cited by 40
First-line diuretics versus other classes of antihypertensive drugs for hypertension
Reinhart, M., Puil, L., Salzwedel, D. M., & Wright, J. M. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008161.pub3 · Cited by 38
Self-citationSystolic Hypertension in the Elderly Program (SHEP). Part 2: Screening and recruitment.
Petrovitch, H., Byington, R. P., Bailey, G., Borhani, P., Carmody, S. E., Goodwin, L., Harrington, J., Johnson, H. A., Johnson, P., & Jones, M. (1991) · Hypertension · doi:10.1161/01.hyp.17.3_suppl.ii16 · Cited by 38
Pearce, K. A., Furberg, C. D., & Rushing, J. (1995) · Archives of Family Medicine · doi:10.1001/archfami.4.11.943 · Cited by 38
Efficacy of treating hypertension in women
the INDANA Investigators, Quan, A., Kerlikowske, K. M., Gueyffier, F., & Boissel, J. (1999) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.1999.12198.x · Cited by 33
Antihypertensive pharmacotherapy for prevention of sudden cardiac death in hypertensive individuals
Taverny, G., Mimouni, Y., LeDigarcher, A., Chevalier, P., Thijs, L., Wright, J. M., & Gueyffier, F. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011745.pub2 · Cited by 33
Self-citationO'MALLEY, K., McCormack, P., & O'Brien, E. T. (1988) · PubMed · Cited by 32
Fuchs, F. D., Fuchs, S. C. P. C., Moreira, L. B., Gus, M., da Nóbrega, A. C. L., Poli‐de‐Figueiredo, C. E., Mion, D., Bortolotto, L. A., Consolim‐Colombo, F. M., Nobre, F. D., et al. (2011) · Trials · doi:10.1186/1745-6215-12-65 · Cited by 32
Kang, S., Wu, Y., An, N., & Ren, M. F. (2004) · Clinical Therapeutics · doi:10.1016/s0149-2918(04)90024-0 · Cited by 29
INSIGHT: international nifedipine GITS study intervention as a goal in hypertension treatment.
Brown, M. J., Castaigne, A., Ruilope, L. M., Mancia, G., Rosenthal, T., de Leeuw, P. W., & Ebner, F. (1996) · PubMed · Cited by 29
Boissel, J., Gueyffier, F., Boutitie, F., Pocock, S., & Fagard, R. H. (2005) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2005.00356.x · Cited by 28
Staessen, J. A., Amery, A., Birkenhäger, W. H., Bulpitt, C. J., Cox, J., de Leeuw, P. W., Cort, P. D., Fagard, R. H., Fletcher, A. E., Forette, F., et al. (1992) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199201000-00017 · Cited by 28
Parsons, C. E., Murad, M. H., Andersen, S., Mookadam, F., & Labonte, H. R. (2016) · Future Cardiology · doi:10.2217/fca.15.90 · Cited by 28
Perry, H. M., McDonald, R. H., Hulley, S. B., Wm, S., Cd, F., Greenlick, M. R., Kuller, L. H., Hw, S., Schoenberger, J. A., & Tm, V. (1986) · PubMed · Cited by 24
Cited by
Meschia, J. F., Bushnell, C., Boden-Albala, B., Braun, L. T., Bravata, D. M., Chaturvedi, S., Creager, M. A., Eckel, R. H., Elkind, M. S. V., Fornage, M., et al. (2014) · Stroke · doi:10.1161/str.0000000000000046 · Cited by 2,650
2024 ESC Guidelines for the management of elevated blood pressure and hypertension
McEvoy, J. W., McCarthy, C. P., Bruno, R. M., Brouwers, S., Canavan, M. D., Ceconi, C., Christodorescu, R. M., Daskalopoulou, S. S., Ferro, C. J., Gerdts, E., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae178 · Cited by 2,298
Statins for the primary prevention of cardiovascular disease
Taylor, F., Huffman, M. D., Macedo, A. F., Moore, T. H., Burke, M., Davey Smith, G., Ward, K., Ebrahim, S., & Gay, H. C. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004816.pub5 · Cited by 1,934
Mancia, G., Laurent, S., Agabiti-Rosei, E., Ambrosioni, E., Burnier, M., Caulfield, M. J., Cifkova, R., Clément, D., Coca, A., Dominiczak, A., et al. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e328333146d · Cited by 1,643
Mancia, G., Laurent, S., Agabiti-Rosei, E., Ambrosioni, E., Burnier, M., Caulfield, M. J., Cifkova, R., Clément, D., Coca, A., Dominiczak, A., et al. (2009) · Blood Pressure · doi:10.3109/08037050903450468 · Cited by 894
Metadata
- Authors
- Wright, J. M., Musini, V. M., & Gill, R.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2018-04-18
- Volume
- 2018
- Issue
- 4
- Pages
- CD001841-CD001841
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W2129832544
- Cited by
- 452
- References
- 214
- FWCI
- 19.78
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.